Correlation Between Mereo BioPharma and Assembly Biosciences
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Assembly Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Assembly Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Assembly Biosciences, you can compare the effects of market volatilities on Mereo BioPharma and Assembly Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Assembly Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Assembly Biosciences.
Diversification Opportunities for Mereo BioPharma and Assembly Biosciences
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Mereo and Assembly is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Assembly Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Assembly Biosciences and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Assembly Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Assembly Biosciences has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Assembly Biosciences go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Assembly Biosciences
Given the investment horizon of 90 days Mereo BioPharma Group is expected to under-perform the Assembly Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Mereo BioPharma Group is 1.15 times less risky than Assembly Biosciences. The stock trades about -0.06 of its potential returns per unit of risk. The Assembly Biosciences is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 1,481 in Assembly Biosciences on November 25, 2024 and sell it today you would lose (246.00) from holding Assembly Biosciences or give up 16.61% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Mereo BioPharma Group vs. Assembly Biosciences
Performance |
Timeline |
Mereo BioPharma Group |
Assembly Biosciences |
Mereo BioPharma and Assembly Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Mereo BioPharma and Assembly Biosciences
The main advantage of trading using opposite Mereo BioPharma and Assembly Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Assembly Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Assembly Biosciences will offset losses from the drop in Assembly Biosciences' long position.Mereo BioPharma vs. Terns Pharmaceuticals | ||
Mereo BioPharma vs. PDS Biotechnology Corp | ||
Mereo BioPharma vs. Inozyme Pharma | ||
Mereo BioPharma vs. Hookipa Pharma |
Assembly Biosciences vs. Spero Therapeutics | ||
Assembly Biosciences vs. Achilles Therapeutics PLC | ||
Assembly Biosciences vs. Instil Bio | ||
Assembly Biosciences vs. CytomX Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories |